Health ❯ Medical Research ❯ Cancer Research
Risks of Gene Editing CAR-T Cell Therapy CAR T Cell Technology Therapeutic Interventions
Phase 1/2a testing confirmed safe tumor-targeted interferon-α delivery with clear evidence of microenvironment reprogramming.